To assess treatment satisfication and Quality of Life (QoL) in patients with MMN who self-infuse high dose subcutaneous immunoglobulin therapy (SCIg) independently in the home environment
| Type of Project | Research Grant |
|---|---|
| Status | Project Complete |
| Funder(s) | Baxter Healthcare Limited |
| Value | £10,886.00 |
| Project Dates | Jan 1, 2011 - Jan 1, 2013 |